• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Device Problems Material Invagination (1336); Insufficient Information (3190); Activation Failure (3270)
Patient Problem Aortic Valve Stenosis (1717)
Event Date 12/12/2018
Event Type  Injury  
Manufacturer Narrative
Device disposition not presently known.
 
Event Description
A perceval pvs23 was implanted on (b)(6) 2018.On (b)(6) 2018, the valve was reportedly explanted due to stenosis of the device.No other information was provided.
 
Event Description
A perceval pvs23 was implanted on (b)(6) 2018.On (b)(6) 2018, the valve was reportedly explanted due to stenosis of the device.It was reported that the valve was deformed and an attempt was made to balloon-dilate the device on december 20, 2018; however, the valve did not regain its original shape.A thoracotomy was therefore performed to remove the device and a medtronic biological valve was implanted.The re-operation went well and the patient returned to the ward, although post-operative electrocardiogram revealed third degree av block and a permanent pacemaker was implanted on (b)(6) 2018.
 
Manufacturer Narrative
The manufacturing and material records for the perceval heart valve, model #icv1209 , s/n # (b)(6), as they pertain to the reported event, were retrieved and reviewed by quality engineering at livanova canada corp.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1209) perceval heart valve at the time of manufacture and release.The manufacturer has followed up for the return of the device; however, the device has not been received to date.As such, the device cannot be investigated and the root cause of the event cannot be established.Based on the document review performed, no manufacturing deficiencies were identified.If the device is received in the future, appropriate investigative action will be taken.
 
Manufacturer Narrative
The manufacturer was informed that the event date was updated.The remainder of the information previously submitted remains unchanged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, bc
MDR Report Key8257839
MDR Text Key133387595
Report Number3004478276-2019-00115
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)191017
Combination Product (y/n)N
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 08/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/17/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/17/2019
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was the Report Sent to FDA? No
Date Manufacturer Received07/29/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-